On Apr 14, 2026, SURG reported earnings of -0.67 USD per share (EPS) for Q4 25, missing the estimate of -0.16 USD, resulting in a -310.54% surprise. Revenue reached 16.19 million, compared to an expected 21.58 million, with a -24.99% difference. The market reacted with a -33.60% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.19 USD, with revenue projected to reach 15.80 million USD, implying an decrease of -71.64% EPS, and decrease of -2.35% in Revenue from the last quarter.